{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Soleno Therapeutics, Inc."},"Symbol":{"label":"Symbol","value":"SLNO"},"Address":{"label":"Address","value":"203 REDWOOD SHORES PARKWAY,SUITE 500, REDWOOD CITY, California, 94065, United States"},"Phone":{"label":"Phone","value":"+1 650 213-8444"},"Industry":{"label":"Industry","value":"Biotechnology: Electromedical & Electrotherapeutic Apparatus"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome."},"CompanyUrl":{"label":"Company Url","value":"https://www.soleno.life"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Anish Bhatnagar","title":"President, Chief Executive & Operating Officer"},{"name":"Kristen Yen","title":"Vice President-Clinical Operations"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}